Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37


Adiponectin and interleukin-6, but not adipose tissue, are associated with worse neurocognitive function in HIV-infected men.

Lake JE, Vo QT, Jacobson LP, Sacktor N, Miller EN, Post WS, Becker JT, Palella FJ Jr, Ragin A, Martin E, Munro CA, Brown TT.

Antivir Ther. 2015 Mar 26. doi: 10.3851/IMP2952. [Epub ahead of print]


Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study.

Abraham AG, Darilay A, McKay H, Margolick JB, Estrella MM, Palella FJ Jr, Bolan R, Rinaldo CR, Jacobson LP.

J Infect Dis. 2015 Mar 11. pii: jiv159. [Epub ahead of print]


Elevated Levels of Monocyte Activation Markers Are Associated With Subclinical Atherosclerosis in Men With and Those Without HIV Infection.

McKibben RA, Margolick JB, Grinspoon S, Li X, Palella FJ Jr, Kingsley LA, Witt MD, George RT, Jacobson LP, Budoff M, Tracy RP, Brown TT, Post WS.

J Infect Dis. 2015 Apr 15;211(8):1219-28. doi: 10.1093/infdis/jiu594. Epub 2014 Oct 30.


Short communication: high cellular iron levels are associated with increased HIV infection and replication.

Chang HC, Bayeva M, Taiwo B, Palella FJ Jr, Hope TJ, Ardehali H.

AIDS Res Hum Retroviruses. 2015 Mar;31(3):305-12. doi: 10.1089/aid.2014.0169. Epub 2014 Oct 7.


The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status.

Estrella MM, Li M, Tin A, Abraham AG, Shlipak MG, Penugonda S, Hussain SK, Palella FJ Jr, Wolinsky SM, Martinson JJ, Parekh RS, Kao WH.

Clin Infect Dis. 2015 Feb 15;60(4):646-52. doi: 10.1093/cid/ciu765. Epub 2014 Oct 3.


Inaccuracy of haemoglobin A1c among HIV-infected men: effects of CD4 cell count, antiretroviral therapies and haematological parameters.

Slama L, Palella FJ Jr, Abraham AG, Li X, Vigouroux C, Pialoux G, Kingsley L, Lake JE, Brown TT.

J Antimicrob Chemother. 2014 Dec;69(12):3360-7. doi: 10.1093/jac/dku295. Epub 2014 Aug 4.


Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS).

Palella FJ Jr, Armon C, Buchacz K, Chmiel JS, Novak RM, D'Aquila RT, Brooks JT; HOPS Investigators.

J Antimicrob Chemother. 2014 Oct;69(10):2826-34. doi: 10.1093/jac/dku190. Epub 2014 Jun 16.


Epicardial fat is associated with duration of antiretroviral therapy and coronary atherosclerosis.

Brener M, Ketlogetswe K, Budoff M, Jacobson LP, Li X, Rezaeian P, Razipour A, Palella FJ Jr, Kingsley L, Witt MD, George RT, Post WS.

AIDS. 2014 Jul 17;28(11):1635-44. doi: 10.1097/QAD.0000000000000116.


Associations between HIV infection and subclinical coronary atherosclerosis.

Post WS, Budoff M, Kingsley L, Palella FJ Jr, Witt MD, Li X, George RT, Brown TT, Jacobson LP.

Ann Intern Med. 2014 Apr 1;160(7):458-67. doi: 10.7326/M13-1754.


HIV therapy, metabolic and cardiovascular health are associated with glomerular hyperfiltration among men with and without HIV infection.

Ng DK, Jacobson LP, Brown TT, Palella FJ Jr, Martinson JJ, Bolan R, Miller ER 3rd, Schwartz GJ, Abraham AG, Estrella MM.

AIDS. 2014 Jan 28;28(3):377-86. doi: 10.1097/QAD.0000000000000094.


Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants.

Palella FJ Jr, Fisher M, Tebas P, Gazzard B, Ruane P, Van Lunzen J, Shamblaw D, Flamm J, Ebrahimi R, Porter D, White K, Hindman J, Elbert E, De-Oertel S, Fralich T.

AIDS. 2014 Jan 28;28(3):335-44. doi: 10.1097/QAD.0000000000000087. Erratum in: AIDS. 2014 Aug 24;28(13):1999-2001.


Risk factors for fatty liver in the Multicenter AIDS Cohort Study.

Price JC, Seaberg EC, Latanich R, Budoff MJ, Kingsley LA, Palella FJ Jr, Witt MD, Post WS, Thio CL.

Am J Gastroenterol. 2014 May;109(5):695-704. doi: 10.1038/ajg.2014.32. Epub 2014 Mar 18.


Factors affecting glomerular filtration rate, as measured by iohexol disappearance, in men with or at risk for HIV infection.

Margolick JB, Jacobson LP, Schwartz GJ, Abraham AG, Darilay AT, Kingsley LA, Witt MD, Palella FJ Jr.

PLoS One. 2014 Feb 7;9(2):e86311. doi: 10.1371/journal.pone.0086311. eCollection 2014.


Increases in duration of first highly active antiretroviral therapy over time (1996-2009) and associated factors in the Multicenter AIDS Cohort Study.

Slama L, Li X, Brown T, Jacobson LP, Pialoux G, Macatangay B, Bolan RK, Phair J, Palella FJ Jr; Multicenter AIDS cohort Study.

J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):57-64. doi: 10.1097/QAI.0b013e3182a99a0d.


Lower adiponectin is associated with subclinical cardiovascular disease among HIV-infected men.

Ketlogetswe KS, Post WS, Li X, Palella FJ Jr, Jacobson LP, Margolick JB, Kingsley LA, Witt MD, Dobs AS, Budoff MJ, Brown TT.

AIDS. 2014 Mar 27;28(6):901-9. doi: 10.1097/QAD.0000000000000186.


Disparities in prevalence of key chronic diseases by gender and race/ethnicity among antiretroviral-treated HIV-infected adults in the US.

Buchacz K, Baker RK, Palella FJ Jr, Shaw L, Patel P, Lichtenstein KA, Chmiel JS, Vellozzi C, Debes R, Henry K, Overton ET, Bush TJ, Tedaldi E, Carpenter C, Mayer KH, Brooks JT; HIV Outpatient Study Investigators.

Antivir Ther. 2013;18(1):65-75. doi: 10.3851/IMP2450. Epub 2012 Oct 30.


Increased mortality among publicly insured participants in the HIV Outpatient Study despite HAART treatment.

Palella FJ Jr, Baker RK, Buchacz K, Chmiel JS, Tedaldi EM, Novak RM, Durham MD, Brooks JT; HOPS Investigators.

AIDS. 2011 Sep 24;25(15):1865-76. doi: 10.1097/QAD.0b013e32834b3537.


Chronic kidney disease and estimates of kidney function in HIV infection: a cross-sectional study in the multicenter AIDS cohort study.

Estrella MM, Parekh RS, Astor BC, Bolan R, Evans RW, Palella FJ Jr, Jacobson LP.

J Acquir Immune Defic Syndr. 2011 Aug 15;57(5):380-6. doi: 10.1097/QAI.0b013e318222f461.


Cardiovascular disease in HIV infection.

Palella FJ Jr, Phair JP.

Curr Opin HIV AIDS. 2011 Jul;6(4):266-71. doi: 10.1097/COH.0b013e328347876c. Review.


Low incidence of renal impairment observed in tenofovir-treated patients.

O'Donnell EP, Scarsi KK, Darin KM, Gerzenshtein L, Postelnick MJ, Palella FJ Jr.

J Antimicrob Chemother. 2011 May;66(5):1120-6. doi: 10.1093/jac/dkr039. Epub 2011 Feb 17.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk